Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Body weight and DOAC trough concentrations study
NL-OMON46689Active, not recruiting
- Sponsor
- HagaZiekenhuis
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of apixaban, rivaroxaban, edoxaban and dabigatran (4 arms), sponsored by HagaZiekenhuis. Started Mar 2018; status: active, not recruiting.
02
Drugs
apixabanrivaroxabanedoxabandabigatran
Beyond the preview
Go deeper on NL-OMON46689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46689.